Published in J Exp Med on November 05, 2001
Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med (2003) 3.02
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med (2003) 2.91
Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med (2002) 2.68
The integration of T cell migration, differentiation and function. Nat Rev Immunol (2013) 2.42
CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med (2007) 2.39
Mechanisms and consequences of dendritic cell migration. Immunity (2008) 2.25
Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med (2005) 2.23
Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell (2012) 1.70
New mechanisms and pathways for monocyte recruitment. J Exp Med (2001) 1.25
Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia. J Immunol (2009) 1.25
Differentiation to the CCR2+ inflammatory phenotype in vivo is a constitutive, time-limited property of blood monocytes and is independent of local inflammatory mediators. J Immunol (2005) 1.20
TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines. J Biol Chem (2010) 1.16
CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses. J Exp Med (2010) 1.10
Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma. J Immunother (2010) 1.10
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol (2002) 1.06
CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung. Exp Lung Res (2008) 1.06
Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood (2007) 1.03
CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis. Clin Exp Immunol (2015) 0.89
Phenotypic modulation of the stromal reticular network in normal and neoplastic lymph nodes: tissue transglutaminase reveals coordinate regulation of multiple cell types. Am J Pathol (2003) 0.88
The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection. Dis Model Mech (2015) 0.87
Lymphocyte migration into atherosclerotic plaque. Arterioscler Thromb Vasc Biol (2014) 0.85
Molecular mechanisms of liver metastasis. Int J Clin Oncol (2011) 0.83
Fine-tuning immune surveillance by fever-range thermal stress. Immunol Res (2010) 0.82
Leishmania amazonensis infection impairs dendritic cell migration from the inflammatory site to the draining lymph node. BMC Infect Dis (2014) 0.81
The role of macrophage class a scavenger receptors in a laser-induced murine choroidal neovascularization model. Invest Ophthalmol Vis Sci (2013) 0.79
Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans. Int J Inflam (2011) 0.79
Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse. Arthritis Res Ther (2014) 0.79
TNF controls the infiltration of dendritic cells into the site of Leishmania major infection. Med Microbiol Immunol (2007) 0.79
Th1 cell induction in lymph nodes according to a red-blue chemokine map. Immunity (2012) 0.78
Immunotherapy with myeloid cells for tolerance induction. Curr Opin Organ Transplant (2010) 0.78
IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol (2013) 0.77
Understanding high endothelial venules: Lessons for cancer immunology. Oncoimmunology (2015) 0.76
Distribution of porcine monocytes in different lymphoid tissues and the lungs during experimental Actinobacillus pleuropneumoniae infection and the role of chemokines. Vet Res (2013) 0.76
IL-21 promotes late activator APC-mediated T follicular helper cell differentiation in experimental pulmonary virus infection. PLoS One (2014) 0.75
Lymphocyte homing and homeostasis. Science (1996) 13.26
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med (1999) 8.01
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell (1998) 7.46
T-cell function and migration. Two sides of the same coin. N Engl J Med (2000) 6.47
Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity (1999) 5.23
Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J Exp Med (1976) 5.07
Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol (1992) 4.50
Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol (1997) 4.27
Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol (2000) 4.20
Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med (1999) 3.78
Distinct roles of L-selectin and integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined. Immunity (1995) 3.38
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med (2000) 3.15
CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J Exp Med (2000) 3.09
Human Mig chemokine: biochemical and functional characterization. J Exp Med (1995) 2.67
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol (1997) 2.53
Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol (1995) 2.48
The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med (2000) 2.35
Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis (1999) 2.35
Chemokines and atherosclerosis. Atherosclerosis (1999) 2.14
Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum (2001) 1.91
In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha. J Immunol (1999) 1.45
Anti-CD43 inhibits monocyte-endothelial adhesion in inflammation and atherogenesis. Blood (1997) 1.09
Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the ApoE knockout mouse. J Vasc Res (2000) 1.06
Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. Atherosclerosis (2000) 1.01
Ablation of tumor necrosis factor receptor type I (p55) alters oxygen-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2000) 0.93
Monocyte adhesion and transmigration in atherosclerosis. Coron Artery Dis (1994) 0.90
T-lymphocytes and monocytes in atherogenesis. Herz (1998) 0.83
A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature (2000) 6.89
Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sci U S A (1991) 5.86
Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science (1989) 4.57
Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science (2000) 4.41
A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 4.39
Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med (1999) 3.78
L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature (1993) 3.45
Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol (1997) 3.24
CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A (1999) 3.00
Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med (1982) 2.79
DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity (2000) 2.75
Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity (2000) 2.64
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol (1997) 2.53
The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med (2000) 2.35
Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol (1994) 2.29
MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature (1993) 2.00
Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature (1994) 1.98
The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol (1999) 1.73
Induction of IgE-secreting cells and IgE isotype-specific suppressor T cells in the respiratory lymph nodes of rats in response to antigen inhalation. Cell Immunol (1985) 1.73
Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J Exp Med (1997) 1.56
Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity (2001) 1.53
Sonographic findings in perforation of the gallbladder. AJR Am J Roentgenol (1982) 1.51
Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med (1996) 1.44
An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J Exp Med (1998) 1.36
The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. Proc Natl Acad Sci U S A (1991) 1.33
Anti-phosphocholine hybridoma antibodies. I. Direct evidence for three distinct families of antibodies in the murine response. J Exp Med (1981) 1.31
Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation (1994) 1.31
Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol (1996) 1.27
Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families. J Exp Med (1981) 1.25
Induction of IgE-isotype specific tolerance by passive antigenic stimulation of the respiratory mucosa. Immunology (1983) 1.24
Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice. Cancer Res (1999) 1.22
Specialization of mucosal follicular dendritic cells revealed by mucosal addressin-cell adhesion molecule-1 display. J Immunol (1997) 1.19
TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J Immunol (1998) 1.18
Chemokines and B-cell homing to follicles. Curr Top Microbiol Immunol (1999) 1.17
Suppression of IgE responses in inbred rats by repeated respiratory tract exposure to antigen: responder phenotype influences isotype specificity of induced tolerance. Eur J Immunol (1984) 1.17
Gene targeting in C57BL/6 ES cells. Successful germ line transmission using recipient BALB/c blastocysts developmentally matured in vitro. Nucleic Acids Res (1997) 1.17
Gene knock-out technology: a methodological overview for the interested novice. J Immunol Methods (1995) 1.14
The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. J Mol Cell Immunol (1984) 1.13
Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia. Br J Ophthalmol (1995) 1.09
Production of a histamine-releasing lymphokine by antigen- or mitogen-stimulated human peripheral T cells. Clin Exp Immunol (1981) 1.08
In vivo administration of antibody to interleukin-5 inhibits increased generation of eosinophils and their progenitors in bone marrow of parasitized mice. Blood (1990) 1.07
T-cell subsets: chemokine receptors guide the way. Curr Biol (1998) 1.05
The mechanism of inhibition of experimental allergic encephalomyelitis in the rat by monoclonal antibody against CD4. J Neuroimmunol (1986) 1.04
Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Immunol Cell Biol (1996) 1.03
Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF receptor-ligand interactions nor CD95 (Fas, APO-1). Eur J Immunol (2000) 1.01
Suppression of IgE responses by antigen inhalation: studies on the role of genetic and environmental factors. Immunology (1987) 1.00
Kinetics and distribution of antigen-specific IgE-secreting cells during the primary antibody response in the rat. J Exp Med (1983) 0.97
Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur J Immunol (1997) 0.97
Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models. Am J Hum Genet (1999) 0.96
The effects of idiotype on the ability of IgG1 anti-phosphorylcholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. Eur J Immunol (1984) 0.96
Tissue digestion with dispase substantially reduces lymphocyte and macrophage cell-surface antigen expression. J Immunol Methods (1996) 0.95
Down-regulation of immune responses to inhaled antigen: studies on the mechanism of induced suppression. Immunology (1985) 0.95
Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J Exp Med (1998) 0.95
Long-lived IgE- and IgG-secreting cells in rodents manifesting persistent antibody responses. Cell Immunol (1984) 0.94
Mechanism of airway inflammation in asthma. Am Rev Respir Dis (1993) 0.94
Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1995) 0.93
Generation of monoclonal antibodies specific for mouse apolipoprotein B-100 in apolipoprotein B-48-only mice. J Lipid Res (1999) 0.93
Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol (1996) 0.91
flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J Immunol (1996) 0.91
Differences between Bombay and Rhnull phenotypes. Vox Sang (1974) 0.88
ELISA plaque assay for the detection of antibody secreting cells: observations on the nature of the solid phase and on variations in plaque diameter. J Immunol Methods (1984) 0.88
Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype. J Exp Med (2000) 0.87
Anti-CD43 monoclonal antibody L11 blocks migration of T cells to inflamed pancreatic islets and prevents development of diabetes in nonobese diabetic mice. J Immunol (1999) 0.87
The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. An overview. J Immunol Methods (1986) 0.86
Interleukin-6. A multifunctional regulator of growth and differentiation. Ann N Y Acad Sci (1989) 0.86
Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy. Liver (2000) 0.85
Multiple deficiencies underlie NK cell inactivity in lymphotoxin-alpha gene-targeted mice. J Immunol (1999) 0.84
Enumeration of human immunoglobulin-secreting cells by the ELISA-plaque method: IgE and IgG isotypes. Clin Immunol Immunopathol (1984) 0.84
Antigen-specific anti-phosphocholine antibodies: binding site studies. J Immunol (1985) 0.81
Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin. J Immunol (1999) 0.80
Increased thymic B cells but maintenance of thymic structure, T cell differentiation and negative selection in lymphotoxin-alpha and TNF gene-targeted mice. Dev Immunol (2000) 0.80
Recirculating and marginal zone B cell populations can be established and maintained independently of primary and secondary follicles. Immunol Cell Biol (2001) 0.80
Allele-specific PCR analysis for detection of the gld Fas-ligand point mutation. J Immunol Methods (1997) 0.79
TNF modulates susceptibility to UVB-induced systemic immunomodulation in mice by effects on dermal mast cell prevalence. Eur J Immunol (1998) 0.79
Red cell genetic abnormalities in the tribes of five districts of Madhya Pradesh. Indian J Med Res (1987) 0.78
Induction of IgE-secreting cells in the lymphatic drainage of the lungs of rats following passive antigen inhalation. Int Arch Allergy Appl Immunol (1986) 0.78
Lymphotoxin controls alphaEbeta7-integrin expression by peripheral CD8+ T cells. Immunol Cell Biol (2001) 0.77
Idiotypes of anti-phosphocholine antibodies: structural correlates. Ann Immunol (Paris) (1984) 0.77
Bombay (Oh) phenotype in two generations in an Indian family. Vox Sang (1976) 0.77
The Peyer's patch microenvironment suppresses T cell responses to chemokines and other stimuli. J Immunol (2001) 0.77
Regulation of hemopoietic cell development by interleukins 4, 5 and 6. Immunol Res (1989) 0.77
Delayed kinetics of tumor necrosis factor-mediated bystander lysis by peptide-specific CD8+ cytotoxic T lymphocytes. Eur J Immunol (1998) 0.76
Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis. Immunol Cell Biol (1998) 0.76
Interleukin-10 promotes the growth of megakaryocyte, mast cell, and multilineage colonies: analysis with committed progenitors and Thy1loSca1+ stem cells. Exp Hematol (1994) 0.76
Studies on seed extracts. II. Interaction of erythrocytes of various animal species with seed agglutinins (lectins). Indian Vet J (1970) 0.75
Serology and genetics of the A1 high H subgroup. Vox Sang (1974) 0.75
L11, a unique anti-CD43 monoclonal antibody, inhibits the adoptive transfer of diabetes and pancreatic islet, salivary gland, and lacrimal gland inflammation in NOD/scid mice. Cell Immunol (1999) 0.75
Novel concepts of tumor necrosis factor action in autoimmune pathology. Curr Dir Autoimmun (2000) 0.75
The role of a novel VH sequence (V11) in the formation of anti-phosphocholine antibodies. Mol Immunol (1984) 0.75
AHm phenotype in an Indian Muslim. Indian J Med Res (1974) 0.75
Variations in the Le a in Oh (Bombay) phenotype during pregnancy. Indian J Med Sci (1971) 0.75
Acquired B character caused by E. coli 0124 bacterial infection: a case report. Indian J Med Res (1972) 0.75